Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway

Abstract

Aim

An impaired biological response to insulin in the brain, known as central insulin resistance, was identified during stroke and traumatic brain injury, for which glutamate excitotoxicity is a common pathogenic factor. The exact molecular link between excitotoxicity and central insulin resistance remains unclear. To explore this issue, the present study aimed to investigate the effects of glutamate-evoked increases in intracellular free Ca2+ concentrations [Ca2+]i and mitochondrial depolarisations, two key factors associated with excitotoxicity, on the insulin-induced activation of the insulin receptor (IR) and components of the Akt/ mammalian target of rapamycin (mTOR) pathway in primary cultures of rat cortical neurons.

Methods

Changes in [Ca2+]i and mitochondrial inner membrane potentials (ΔΨm) were monitored in rat cultured cortical neurons, using the fluorescent indicators Fura-FF and Rhodamine 123, respectively. The levels of active, phosphorylated signalling molecules associated with the IR/Akt/mTOR pathway were measured with the multiplex fluorescent immunoassay.

Results

When significant mitochondrial depolarisations occurred due to glutamate-evoked massive influxes of Ca2+ into the cells, insulin induced 48% less activation of the IR (assessed by IR tyrosine phosphorylation, pY1150/1151), 72% less activation of Akt (assessed by Akt serine phosphorylation, pS473), 44% less activation of mTOR (assessed by mTOR pS2448), and 38% less inhibition of glycogen synthase kinase β (GSK3β) (assessed by GSK3β pS9) compared with respective controls. These results suggested that excitotoxic glutamate inhibits signalling via the IR/Akt/mTOR pathway at multiple levels, including the IR, resulting in the development of acute neuronal insulin resistance within minutes, as an early pathological event associated with excitotoxicity.

Main text

An acute impairment in the biological response to insulin in the brain, known as central insulin resistance, was identified during stroke [1] and traumatic brain injury [2], for which excitotoxicity, which is caused by excessive glutamate release, is a key pathogenic factor [3].

The exact molecular link between insulin resistance and glutamate excitotoxicity remains unclear. Based on published data, an abnormal rise in intracellular free Ca2+ concentration ([Ca2+]i) and decreased mitochondrial inner membrane potential (ΔΨm) are factors associated with the excitotoxic glutamate [4,5,6], which could potentially affect insulin signalling. The presence of Ca2+ (1 mM) has been shown to reduce the insulin-induced tyrosine phosphorylation of the insulin receptor (IR) in hippocampal synaptic preparations [7]. Glutamate has been shown to reduce the tyrosine phosphorylation of the IR when added after the prolonged insulin-mediated stimulation of hippocampal neuronal cultures [8]. Protonophore-induced decreases in ΔΨm have been shown to evoke concomitant decreases in the IR tyrosine phosphorylation in response to insulin, indicating that mitochondrial depolarisation is an independent causative factor for neuronal insulin resistance [9]. However, the effects of glutamate-evoked changes in [Ca2+]i and ΔΨm on the insulin-induced activation of the IR/Akt/mammalian target of rapamycin (mTOR) and glycogen synthase kinase (GSK)3β pathways have never been studied. Here, we investigated whether excitotoxic glutamate affects the insulin-induced phosphorylation of IR/Akt/mTOR pathway components during significant mitochondrial depolarisations caused by the massive influx of Ca2+ into the cells.

To determine the times during which glutamate induces significant mitochondrial depolarisation, rat cortical neurons were exposed to 100 μM glutamate and changes in [Ca2+]i, and ΔΨm were monitored for 30 min. Detailed methods for the preparation of primary cortical neuronal cultures and measuring [Ca2+]i and ΔΨm are described in Additional file 1. As expected, glutamate evoked a rapid increase in [Ca2+]i, followed by a decreased in ΔΨm in the cells (Fig. 1a and b, Additional file 2: Tables S3 and S4). After 30 min of glutamate exposure, the mean [Ca2+]i level increased by 2.4-fold above baseline (F148,8732 = 44.8, P < 0.0001), and the mean ΔΨm value significantly decreased by 1.6-fold below baseline (F148,8732 = 182.8, P < 0.0001) (Fig. 1a–c, one-way analysis of variance [ANOVA] with repeated measures, followed by Tukey’s post hoc test). Therefore, the 30-min interval for glutamate exposure was selected for subsequent experiments.

Fig. 1
figure1

Excitotoxic glutamate inhibits IR/Akt/mTOR pathway

a Dynamics of [Ca2+]i and b ΔΨm in single rat cortical neurons, loaded simultaneously with Fura-FF and Rh123 dyes and exposed to 100 μM glutamate. Grey lines represent sixty single neurons. Blue and red lines represent the respective means of [Ca2+]i and ΔΨm, averaged across sixty individual neurons at every time point. c Fura-FF and Rh123 fluorescence 30 min after the onset of glutamate exposure, expressed as the fold increase over baseline (at − 5 min). Data are the mean ± SEM from sixty neurons. ****P < 0.0001 compared to respective baselines (one-way ANOVA with repeated measures, followed by Tukey’s post hoc test). d-g Levels of d IRβ pY1150/1151, e Akt pS473, f mTOR pS2448, and g GSK3β pS9 in rat cortical neurons exposed to 0 nM (C) or 100 nM insulin for 15 min (I), 100 μM glutamate for 30 min g, or sequentially to 100 μM glutamate for 30 min and 100 nM insulin for 15 min (G + I). Bar graphs represent the levels of the phosphoproteins, normalised against respective total protein levels, in cell lysates and expressed as a percentage of levels in insulin-treated cells (group I). Each value represents the mean ± SEM from six independent cultures (cell populations obtained from twelve separate rats, two per culture). ###P < 0.001, ####P < 0.0001 compared with untreated control c; **P < 0.01, ***P < 0.001, ****P < 0.0001 compared with insulin i (one-way ANOVA, followed by Tukey’s post hoc test for multiple comparisons). h Scheme illustrating the inhibitory effects of glutamate on the insulin-induced activation of the IR/Akt/mTOR pathway.

Next, we investigated the effects of glutamate on the insulin-induced activation of signalling molecules in the IR/Akt/mTOR and GSK3β pathways. Rat cortical neuronal cultures were sequentially exposed to either 100 μM excitotoxic glutamate concentration or no glutamate for 30 min, then stimulated with 100 nM insulin for 15 min and lysed. The levels of the tyrosine-phosphorylated IR β-subunit (IRβ pY1150/1151), the serine-phosphorylated Ser/Thr kinase Akt (Akt pS473), the serine-phosphorylated mammalian target of rapamycin (mTOR pS2448), and the serine-phosphorylated glycogen synthase kinase 3β (GSK3β pS9) were measured in the cell lysates and normalised against the total levels of these proteins, as outlined in Additional file 1. A one-way ANOVA analysis revealed a significant difference between groups for IRβ pY1150/1151 (Fig. 1d, F3,20 = 23.62, P < 0.0001), Akt pS473 (Fig. 1e, F3,20 = 388.6, P < 0.0001), mTOR pS2448 (Fig. 1f, F3,20 = 19.69, P < 0.0001), and GSK3β pS9 (Fig. 1g, F3,20 = 4.48, P = 0.0146). Tukey’s multiple comparisons test showed that insulin stimulation resulted in a significant increase in IRβ pY1150/1151 (Fig. 1d, P < 0.0001), Akt pS473 (Fig. 1e, P < 0.0001), and mTOR pS2448 (Fig. 1f, P < 0.001) levels compared with their respective controls (Additional file 1: Tables S1 and S2). In the glutamate pre-treated neurons, insulin induced 48% less IR phosphorylation at pY1150/1151 (Fig. 1d, P < 0.001), 72% less Akt phosphorylation at pS473 (Fig. 1e, P < 0.0001), 44% less mTOR phosphorylation at pS2448 (Fig. 1f, P < 0.0001), and 38% less GSK3β phosphorylation at pS9 (Fig. 1g, P < 0.01) compared with non-glutamate treated controls. Neuronal IR becomes fully active following autophosphorylation at Y1150/1151 [10], which triggers downstream signalling via the Akt/mTOR and GSK3β pathways. The serine-phosphorylation of Akt at S473 [11] and mTOR at S2448 [12] are crucial for their activation, whereas the serine-phosphorylation of GSK3β at S9 [13] leads to its inhibition. Therefore, our results suggested that excitotoxic glutamate inhibits insulin-induced IR activation and the downstream IR/Akt/mTOR signalling pathway (Fig. 1h).

The primary finding of the present study was that excitotoxic glutamate inhibits the IR/Akt/mTOR pathway, resulting in the development of acute neuronal insulin resistance during periods of significant mitochondrial depolarisation caused by glutamate-evoked massive influxes of Ca2+. This rapid loss of neuronal insulin sensitivity appears to be one of the earliest pathological events associated with glutamate excitotoxicity. These results are in complete agreement with our previous findings that mitochondria control IR autophosphorylation in neurons and that mitochondrial depolarisation causes the loss of insulin sensitivity during the IR autophosphorylation stage [9, 14]. Recently we showed that pre-treatment with insulin prevents the glutamate-evoked increases in [Ca2+]i and decreases in ΔΨm, protecting rat cortical neurons against excitotoxicity [15]. The glutamate effect and the protective effects of insulin were both completely abrogated by MK 801, an inhibitor of Ca2+ influx, via the N-methyl-D-aspartate (NMDA) receptor and the plasmalemmal Na+/Ca2+ exchanger operating in reverse mode [15]. Collectively, these findings suggested that the modulation of intracellular Ca2+ levels plays a critical role in negative cross-talk between insulin and glutamate signalling during excitotoxicity. Glutamate induces an increase in [Ca2+]i and a decrease in ΔΨm, which inhibit IR activation. In turn, insulin prevents the glutamate-evoked rise in [Ca2+]i and mitochondrial depolarisation, protecting against excitotoxicity.

In conclusion, this study showed that glutamate excitotoxicity is causative for central insulin resistance and may induce the acute loss of insulin signalling within minutes under mitochondrial depolarisation conditions. Therefore, the use of agents designed to prevent mitochondrial depolarisation may be a reasonable approach to the treatment of acute neuronal insulin resistance during excitotoxicity.

Availability of data and materials

All data are available in the Additional file 1 and Additional file 2.

Abbreviations

[Ca2+]i :

Intracellular free Ca2+ concentration

Akt:

The Ser/Thr kinase Akt

ANOVA:

analysis of variance

GSK3β:

The glycogen synthase kinase 3β

IR:

Insulin receptor

IRβ:

Insulin receptor β-subunit

mTOR:

The mammalian target of rapamycin

ΔΨm :

Mitochondrial inner membrane potential

References

  1. 1.

    Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157–88.

    CAS  Article  Google Scholar 

  2. 2.

    Karelina K, Sarac B, Freeman LM, Gaier KR, Weil ZM. Traumatic brain injury and obesity induce persistent central insulin resistance. Eur J Neurosci. 2016;43:1034–43.

    Article  Google Scholar 

  3. 3.

    Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 2015;15:27.

    Article  Google Scholar 

  4. 4.

    Nicholls DG. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med. 2004;4:149–77.

    CAS  Article  Google Scholar 

  5. 5.

    Abramov AY, Duchen MR. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta. 1777;2008:953–64.

    Google Scholar 

  6. 6.

    Duchen MR, Surin A, Jacobson J. Imaging mitochondrial function in intact cells. Methods Enzymol. 2003;361:353–89.

    CAS  Article  Google Scholar 

  7. 7.

    Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem. 1999;274:34893–902.

    CAS  Article  Google Scholar 

  8. 8.

    Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J. 2008;22:246–60.

    CAS  Article  Google Scholar 

  9. 9.

    Persiyantseva NA, Storozhevykh TP, Senilova YE, Gorbacheva LR, Pinelis VG, Pomytkin IA. Mitochondrial H2O2 as an enable signal for triggering autophosphorylation of insulin receptor in neurons. J Mol Signal. 2013;8:11.

    Article  Google Scholar 

  10. 10.

    White MF, Kahn CR. The insulin signaling system. J Biol Chem. 1994;269:1–4.

    CAS  PubMed  Google Scholar 

  11. 11.

    Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996;15:6541–51.

    CAS  Article  Google Scholar 

  12. 12.

    Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J. 1999;344:427–31.

    CAS  Article  Google Scholar 

  13. 13.

    Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nat. 1995;378:785–9.

    CAS  Article  Google Scholar 

  14. 14.

    Storozhevykh TP, Senilova YE, Persiyantseva NA, Pinelis VG, Pomytkin IA. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci. 2007;8:84.

    Article  Google Scholar 

  15. 15.

    Krasil'nikova I, Surin A, Sorokina E, Fisenko A, Boyarkin D, Balyasin M, Demchenko A, Pomytkin I, Pinelis V. Insulin protects cortical neurons against glutamate excitotoxicity. Front Neurosci. 2019;13:1027.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by Russian Ministry of Health, the project N. АААА-А19–119012590191-3.

Author information

Affiliations

Authors

Contributions

IK, AS, VP, and IP conceived and designed the experiments. IP wrote the article. IK and ZB performed experiments. IK, VP, and IP analyzed the data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Igor Pomytkin.

Ethics declarations

Ethics approval and consent to participate

Experiments with animals were performed in accordance with the ethical principles and regulatory documents recommended by the European Convention on the Protection of Vertebrate Animals used for experiments (Guide for the Animals and Eighth Edition. 2010), as well as in accordance with the “Good Laboratory Rules practice”, approved by order of the Ministry of Health of the Russian Federation No. 199n of 04/01/2016. The experimental procedures were approved by the Ethics Committee at National Medical Research Center for Children’s Health, Russian Ministry of Health.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pomytkin, I., Krasil’nikova, I., Bakaeva, Z. et al. Excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway. Mol Brain 12, 112 (2019). https://doi.org/10.1186/s13041-019-0533-5

Download citation

Keywords

  • Insulin
  • Glutamate excitotoxicity
  • Central insulin resistance